Cargando…
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and e...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383838/ https://www.ncbi.nlm.nih.gov/pubmed/31853977 http://dx.doi.org/10.1002/ijc.32839 |
_version_ | 1783563500947243008 |
---|---|
author | Kooyker, Arthur I. Toes‐Zoutendijk, Esther Opstal‐van Winden, Annemieke W.J. Spaander, Manon C.W. Buskermolen, Maaike van Vuuren, Hanneke J. Kuipers, Ernst J. van Kemenade, Folkert J. Ramakers, Chris Thomeer, Maarten G.J. Dekker, Evelien Nagtegaal, Iris D. de Koning, Harry J. van Leerdam, Monique E. Lansdorp‐Vogelaar, Iris |
author_facet | Kooyker, Arthur I. Toes‐Zoutendijk, Esther Opstal‐van Winden, Annemieke W.J. Spaander, Manon C.W. Buskermolen, Maaike van Vuuren, Hanneke J. Kuipers, Ernst J. van Kemenade, Folkert J. Ramakers, Chris Thomeer, Maarten G.J. Dekker, Evelien Nagtegaal, Iris D. de Koning, Harry J. van Leerdam, Monique E. Lansdorp‐Vogelaar, Iris |
author_sort | Kooyker, Arthur I. |
collection | PubMed |
description | The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut‐off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut‐off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non‐participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut‐off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut‐off were detected in the subsequent round. |
format | Online Article Text |
id | pubmed-7383838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73838382020-07-27 The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening Kooyker, Arthur I. Toes‐Zoutendijk, Esther Opstal‐van Winden, Annemieke W.J. Spaander, Manon C.W. Buskermolen, Maaike van Vuuren, Hanneke J. Kuipers, Ernst J. van Kemenade, Folkert J. Ramakers, Chris Thomeer, Maarten G.J. Dekker, Evelien Nagtegaal, Iris D. de Koning, Harry J. van Leerdam, Monique E. Lansdorp‐Vogelaar, Iris Int J Cancer Cancer Therapy and Prevention The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut‐off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut‐off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non‐participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut‐off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut‐off were detected in the subsequent round. John Wiley & Sons, Inc. 2020-01-09 2020-08-15 /pmc/articles/PMC7383838/ /pubmed/31853977 http://dx.doi.org/10.1002/ijc.32839 Text en © 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Therapy and Prevention Kooyker, Arthur I. Toes‐Zoutendijk, Esther Opstal‐van Winden, Annemieke W.J. Spaander, Manon C.W. Buskermolen, Maaike van Vuuren, Hanneke J. Kuipers, Ernst J. van Kemenade, Folkert J. Ramakers, Chris Thomeer, Maarten G.J. Dekker, Evelien Nagtegaal, Iris D. de Koning, Harry J. van Leerdam, Monique E. Lansdorp‐Vogelaar, Iris The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening |
title | The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening |
title_full | The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening |
title_fullStr | The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening |
title_full_unstemmed | The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening |
title_short | The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening |
title_sort | second round of the dutch colorectal cancer screening program: impact of an increased fecal immunochemical test cut‐off level on yield of screening |
topic | Cancer Therapy and Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383838/ https://www.ncbi.nlm.nih.gov/pubmed/31853977 http://dx.doi.org/10.1002/ijc.32839 |
work_keys_str_mv | AT kooykerarthuri thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT toeszoutendijkesther thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT opstalvanwindenannemiekewj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT spaandermanoncw thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT buskermolenmaaike thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT vanvuurenhannekej thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT kuipersernstj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT vankemenadefolkertj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT ramakerschris thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT thomeermaartengj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT dekkerevelien thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT nagtegaalirisd thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT dekoningharryj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT vanleerdammoniquee thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT lansdorpvogelaariris thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT kooykerarthuri secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT toeszoutendijkesther secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT opstalvanwindenannemiekewj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT spaandermanoncw secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT buskermolenmaaike secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT vanvuurenhannekej secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT kuipersernstj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT vankemenadefolkertj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT ramakerschris secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT thomeermaartengj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT dekkerevelien secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT nagtegaalirisd secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT dekoningharryj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT vanleerdammoniquee secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening AT lansdorpvogelaariris secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening |